• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

good bye Lapband Reps!


<



Well played General Caggiano/Custer in driving this "billion dollar brand" to Little Big Horn. Maybe wasn't such a good idea to hitch your horses to the billboard sleaze bags?
 








Similar threads

Replies
7
Views
6K
Replies
7
Views
5K
Allergan
Anonymous
Replies
0
Views
2K
Allergan
Anonymous